Matrix metalloproteinases as breast cancer drivers and therapeutic targets.
Ontology highlight
ABSTRACT: Members of the matrix metalloproteinase (MMP) family have been identified as poor prognosis markers for breast cancer patients and as drivers of many facets of the tumor phenotype in experimental models. Early enthusiasm for MMPs as therapeutic targets was tempered following disappointing clinical trials that utilized broad spectrum, small molecule catalytic site inhibitors. However, subsequent research has continued to define key roles for MMPs as breast cancer promoters, to elucidate the complex roles that that these proteins play in breast cancer development and progression, and to identify how these roles are linked to specific and unique biochemical features of individual members of the MMP family. Here, we provide an overview of the structural features of the MMPs, then discuss clini
SUBMITTER: Radisky ES
PROVIDER: S-EPMC4516284 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA